Leonardo A. Rivera-Rivera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leonardo A. Rivera-Rivera has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Kevin M. Johnson
Department of Medical Physics, University of Wisconsin-Madison, Madison, USA
10 shared publications Sterling C. Johnson
Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, USA
9 shared publicationsLaura Eisenmenger
Department of Radiology, University of Wisconsin School of Medicine and Public Health , Madison, WI 53792
7 shared publications- Karly Alex Cody
Department of Neurology and Neurological Sciences Stanford University Stanford California USA
5 shared publications - Oliver Wieben
University of Wisconsin-Madison
5 shared publications - Tobey James Betthauser
University of Wisconsin‐Madison School of Medicine and Public Health, Madison, WI USA
5 shared publications
Latest Publications
- Open Access
- 28 October 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-14
Synchronous quantification of arterial, venous, and cerebrospinal fluid flow dynamics using real-time phase-contrast MRI
Neurofluid flow dynamics are frequently studied from asynchronous blood and CSF flow measurements from real-time imaging using separate phase contrast (PC) MRI scans. Asynchronous measures can be influenced by changes in heart rate, respiration, and other physiological processes, obfuscating neurofluids assessment. Here we present an approach for synchronous measures of neurofluids using simultaneous real-time 2D PC MRI and investigated the effects of different breathing patterns on synchronous and asynchronous blood and CSF flow in a group of healthy participants. Interleaved dual-velocity encoding 2D PC MRI with retrospective real-time reconstruction was utilized for synchronous neurofluid measures during free breathing, paced breathing and breath holds. Data were collected on a clinical 3.0T scanner at the level of C1/C2 vertebrae in 10 participants. From real-time images, flow rates repeated measures, and cardiac and respiratory flow power were assessed using Bland-Altman, power spectral analyses, and breathing pattern group differences. Neurofluids coupling from cross-correlation between arterial and venous blood and CSF flow signals were quantified from synchronous and asynchronous measures. Real-time images were re-binned to the cardiac cycle and compared to high-temporal resolution cardiac-resolved images in terms of flow rate, pulsatility index, and stroke volume. Flow repeatability was highest in free breathing scans and in arteries and spinal canal compared to veins from Bland-Altman and repeatability coefficients. Significant differences were measured in cardiac and respiratory flow power across breathing patterns in various vessel segments and spinal canal (P ≤ 0.006). Synchronous blood and CSF cardiac coupling were significantly higher than asynchronous results in all vessels (P = 0.002). For example, free breathing synchronous cardiac couplings ranged from [0.81, 0.93], compared to asynchronous range [0.49, 0.53]. Synchronous cardiac coupling showed significant differences across breathing patterns in most vessels (P = 0.002). Comparison between real-time cardiac re-binned images and high-temporal resolution cardiac-resolved images showed high correlations for flow rate and spinal canal stroke volume (ρ ≥ 0.95) and lower for pulsatility index (ρ = [0.45, 0.88]). Breathing patterns induced significant responses across neurofluids including in flow rates, flow power, and coupling parameters. Higher cross-correlation among synchronous measures support benefits over asynchronous measures for neurofluids coupling characterization.
- 28 October 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-14
Open AccessSynchronous quantification of arterial, venous, and cerebrospinal fluid flow dynamics using real-time phase-contrast MRI
Neurofluid flow dynamics are frequently studied from asynchronous blood and CSF flow measurements from real-time imaging using separate phase contrast (PC) MRI scans. Asynchronous measures can be influenced by changes in heart rate, respiration, and other physiological processes, obfuscating neurofluids assessment. Here we present an approach for synchronous measures of neurofluids using simultaneous real-time 2D PC MRI and investigated the effects of different breathing patterns on synchronous and asynchronous blood and CSF flow in a group of healthy participants. Interleaved dual-velocity encoding 2D PC MRI with retrospective real-time reconstruction was utilized for synchronous neurofluid measures during free breathing, paced breathing and breath holds. Data were collected on a clinical 3.0T scanner at the level of C1/C2 vertebrae in 10 participants. From real-time images, flow rates repeated measures, and cardiac and respiratory flow power were assessed using Bland-Altman, power spectral analyses, and breathing pattern group differences. Neurofluids coupling from cross-correlation between arterial and venous blood and CSF flow signals were quantified from synchronous and asynchronous measures. Real-time images were re-binned to the cardiac cycle and compared to high-temporal resolution cardiac-resolved images in terms of flow rate, pulsatility index, and stroke volume. Flow repeatability was highest in free breathing scans and in arteries and spinal canal compared to veins from Bland-Altman and repeatability coefficients. Significant differences were measured in cardiac and respiratory flow power across breathing patterns in various vessel segments and spinal canal (P ≤ 0.006). Synchronous blood and CSF cardiac coupling were significantly higher than asynchronous results in all vessels (P = 0.002). For example, free breathing synchronous cardiac couplings ranged from [0.81, 0.93], compared to asynchronous range [0.49, 0.53]. Synchronous cardiac coupling showed significant differences across breathing patterns in most vessels (P = 0.002). Comparison between real-time cardiac re-binned images and high-temporal resolution cardiac-resolved images showed high correlations for flow rate and spinal canal stroke volume (ρ ≥ 0.95) and lower for pulsatility index (ρ = [0.45, 0.88]). Breathing patterns induced significant responses across neurofluids including in flow rates, flow power, and coupling parameters. Higher cross-correlation among synchronous measures support benefits over asynchronous measures for neurofluids coupling characterization.
- Open Access
- 19 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf158
Onset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts
The temporal relationship between cerebrovascular disease (V), indicated by white matter hyperintensities, and beta-amyloid (A) in Alzheimer’s disease remains unclear, prompting speculation about their potential interdependence. Longitudinal data were employed to estimate onset ages and corresponding disease chronicity for A and V (where disease chronicity is calculated as age at measurement minus estimated age of biomarker abnormality onset). In a large, predominantly cognitively unimpaired dataset (n = 877, ages 43–93 years), a V+ threshold was identified, and Sampled Iterative Local Approximation (SILA) was utilized to illustrate the predictable accumulation trajectory of V post-onset. Investigating the temporal association between A and V onset ages and accumulation trajectories in preclinical years, four operationalizations of time were examined across two initially cognitively unimpaired samples (n = 240 primary sample from Wisconsin Registry for Alzheimer’s Prevention; n = 123 replication sample from Wisconsin Alzheimer’s Disease Research Center): (i) chronological age, (ii) estimated V+ chronicity, (iii) years since baseline scan, and (iv) estimated A+ chronicity. Results indicated that while both diseases are age-related, their onsets and trajectories are independent of each other. In addition, results indicated that V and A accumulation trajectories were highly predictable relative to onset of positivity for each biomarker. Cognitive decline across multiple cognitive domains was fastest when both V and A were present based on last available amyloid PET and MRI scan, with greater A chronicity being a more salient predictor of cognitive decline in these samples.
- 19 April 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 7 (3) , fcaf158
Open AccessOnset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts
The temporal relationship between cerebrovascular disease (V), indicated by white matter hyperintensities, and beta-amyloid (A) in Alzheimer’s disease remains unclear, prompting speculation about their potential interdependence. Longitudinal data were employed to estimate onset ages and corresponding disease chronicity for A and V (where disease chronicity is calculated as age at measurement minus estimated age of biomarker abnormality onset). In a large, predominantly cognitively unimpaired dataset (n = 877, ages 43–93 years), a V+ threshold was identified, and Sampled Iterative Local Approximation (SILA) was utilized to illustrate the predictable accumulation trajectory of V post-onset. Investigating the temporal association between A and V onset ages and accumulation trajectories in preclinical years, four operationalizations of time were examined across two initially cognitively unimpaired samples (n = 240 primary sample from Wisconsin Registry for Alzheimer’s Prevention; n = 123 replication sample from Wisconsin Alzheimer’s Disease Research Center): (i) chronological age, (ii) estimated V+ chronicity, (iii) years since baseline scan, and (iv) estimated A+ chronicity. Results indicated that while both diseases are age-related, their onsets and trajectories are independent of each other. In addition, results indicated that V and A accumulation trajectories were highly predictable relative to onset of positivity for each biomarker. Cognitive decline across multiple cognitive domains was fastest when both V and A were present based on last available amyloid PET and MRI scan, with greater A chronicity being a more salient predictor of cognitive decline in these samples.
- Open Access
- 27 March 2025
- Published by MIT Press in Imaging Neuroscience
- Vol. 3
Simultaneous and synchronous characterization of blood and CSF flow dynamics using multiple Venc PC MRI
Neurofluid dynamics are crucial for maintaining brain homeostasis and facilitating the clearance of brain metabolites through the coupling of arterial and venous blood with cerebrospinal fluid (CSF). Two-dimensional phase contrast (PC) magnetic resonance imaging (MRI) is frequently used to study neurofluids; however, separate examinations are typically required for assessing blood and CSF flow, which can confound analyses due to asynchronous physiological measurements. To enable simultaneous assessment of neurofluid dynamics, we describe and evaluate a 2D PC MRI approach in human participant experiments. An interleaved multi-point velocity encoding scheme was integrated into a 2D golden angle spiral PC MRI scan to facilitate synchronous characterization of neurofluids. Two multi-point schemes, including interleaved dual-venc (DV) and triple-venc (MV) scans, were evaluated and compared with standard asynchronous single-venc (SV) scans. Data and repeated scans were collected on a clinical 3.0T scanner at the level of the C1/C2 vertebrae in 10 human participants. From cardiac-resolved images, the relationship between net blood flow and CSF flow pulsatile volume change was characterized using regression modeling. Temporal lags between cardiac-driven arterial blood (vertebral arteries (VAs) and internal carotid arteries (ICAs)) and spinal canal (SC) CSF were estimated with cross-correlation. SV, DV, and MV flow mean, range, and volume changes were studied and compared using linear mixed effect models, intraclass correlation coefficients, Bland–Altman, and Pearson correlations. A strong relationship was measured between net blood flow and CSF flow pulsatile volume change from SV (R2 = 0.71, P = 0.002), DV (R2 = 0.70, P = 0.003), and MV (R2 = 0.78, P < 0.001) scans. SC-VAs temporal lags were statistically longer than SC-ICAs lags across all scans (P < 0.001 for SV, DV, and MV). Bland–Altman analyses and repeatability coefficients indicated that DV and MV scans had the highest repeatability. MV scans generally underestimated SC CSF flow markers relative to SV and DV scans. A more pronounced flow offset in venous measures was identified between SV scans and the DV and MV scans. In conclusion, this study introduced a method for simultaneous imaging of cranio-spinal arterial, venous, and CSF flow, enabling the synchronous assessment of neurofluid dynamics. The results indicated that interleaved DV and MV scans could improve the evaluation of neurofluid coupling compared with asynchronous SV scans.
- 27 March 2025
- Published by MIT Press in Imaging Neuroscience
- Vol. 3
Open AccessSimultaneous and synchronous characterization of blood and CSF flow dynamics using multiple Venc PC MRI
Neurofluid dynamics are crucial for maintaining brain homeostasis and facilitating the clearance of brain metabolites through the coupling of arterial and venous blood with cerebrospinal fluid (CSF). Two-dimensional phase contrast (PC) magnetic resonance imaging (MRI) is frequently used to study neurofluids; however, separate examinations are typically required for assessing blood and CSF flow, which can confound analyses due to asynchronous physiological measurements. To enable simultaneous assessment of neurofluid dynamics, we describe and evaluate a 2D PC MRI approach in human participant experiments. An interleaved multi-point velocity encoding scheme was integrated into a 2D golden angle spiral PC MRI scan to facilitate synchronous characterization of neurofluids. Two multi-point schemes, including interleaved dual-venc (DV) and triple-venc (MV) scans, were evaluated and compared with standard asynchronous single-venc (SV) scans. Data and repeated scans were collected on a clinical 3.0T scanner at the level of the C1/C2 vertebrae in 10 human participants. From cardiac-resolved images, the relationship between net blood flow and CSF flow pulsatile volume change was characterized using regression modeling. Temporal lags between cardiac-driven arterial blood (vertebral arteries (VAs) and internal carotid arteries (ICAs)) and spinal canal (SC) CSF were estimated with cross-correlation. SV, DV, and MV flow mean, range, and volume changes were studied and compared using linear mixed effect models, intraclass correlation coefficients, Bland–Altman, and Pearson correlations. A strong relationship was measured between net blood flow and CSF flow pulsatile volume change from SV (R2 = 0.71, P = 0.002), DV (R2 = 0.70, P = 0.003), and MV (R2 = 0.78, P < 0.001) scans. SC-VAs temporal lags were statistically longer than SC-ICAs lags across all scans (P < 0.001 for SV, DV, and MV). Bland–Altman analyses and repeatability coefficients indicated that DV and MV scans had the highest repeatability. MV scans generally underestimated SC CSF flow markers relative to SV and DV scans. A more pronounced flow offset in venous measures was identified between SV scans and the DV and MV scans. In conclusion, this study introduced a method for simultaneous imaging of cranio-spinal arterial, venous, and CSF flow, enabling the synchronous assessment of neurofluid dynamics. The results indicated that interleaved DV and MV scans could improve the evaluation of neurofluid coupling compared with asynchronous SV scans.
- Open Access
- 17 December 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2572-2584
Incorporating Radiologist Knowledge Into MRI Quality Metrics for Machine Learning Using Rank‐Based Ratings
Background: Deep learning (DL) often requires an image quality metric; however, widely used metrics are not designed for medical images.Purpose: To develop an image quality metric that is specific to MRI using radiologists image rankings and DL models.Study Type: Retrospective.Population: A total of 19,344 rankings on 2916 unique image pairs from the NYU fastMRI Initiative neuro database was used for the neural network‐based image quality metrics training with an 80%/20% training/validation split and fivefold cross‐validation.Field Strength/Sequence: 1.5 T and 3 T T1, T1 postcontrast, T2, and FLuid Attenuated Inversion Recovery (FLAIR).Assessment: Synthetically corrupted image pairs were ranked by radiologists (N = 7), with a subset also scoring images using a Likert scale (N = 2). DL models were trained to match rankings using two architectures (EfficientNet and IQ‐Net) with and without reference image subtraction and compared to ranking based on mean squared error (MSE) and structural similarity (SSIM). Image quality assessing DL models were evaluated as alternatives to MSE and SSIM as optimization targets for DL denoising and reconstruction.Statistical Tests: Radiologists' agreement was assessed by a percentage metric and quadratic weighted Cohen's kappa. Ranking accuracies were compared using repeated measurements analysis of variance. Reconstruction models trained with IQ‐Net score, MSE and SSIM were compared by paired t test. P < 0.05 was considered significant.Results: Compared to direct Likert scoring, ranking produced a higher level of agreement between radiologists (70.4% vs. 25%). Image ranking was subjective with a high level of intraobserver agreement () and lower interobserver agreement (). IQ‐Net and EfficientNet accurately predicted rankings with a reference image ( and ). However, EfficientNet resulted in images with artifacts and high MSE when used in denoising tasks while IQ‐Net optimized networks performed well for both denoising and reconstruction tasks.Data Conclusion: Image quality networks can be trained from image ranking and used to optimize DL tasks.Level of Evidence: 3Technical Efficacy: Stage 1
- 17 December 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2572-2584
Open AccessIncorporating Radiologist Knowledge Into MRI Quality Metrics for Machine Learning Using Rank‐Based Ratings
Background: Deep learning (DL) often requires an image quality metric; however, widely used metrics are not designed for medical images.Purpose: To develop an image quality metric that is specific to MRI using radiologists image rankings and DL models.Study Type: Retrospective.Population: A total of 19,344 rankings on 2916 unique image pairs from the NYU fastMRI Initiative neuro database was used for the neural network‐based image quality metrics training with an 80%/20% training/validation split and fivefold cross‐validation.Field Strength/Sequence: 1.5 T and 3 T T1, T1 postcontrast, T2, and FLuid Attenuated Inversion Recovery (FLAIR).Assessment: Synthetically corrupted image pairs were ranked by radiologists (N = 7), with a subset also scoring images using a Likert scale (N = 2). DL models were trained to match rankings using two architectures (EfficientNet and IQ‐Net) with and without reference image subtraction and compared to ranking based on mean squared error (MSE) and structural similarity (SSIM). Image quality assessing DL models were evaluated as alternatives to MSE and SSIM as optimization targets for DL denoising and reconstruction.Statistical Tests: Radiologists' agreement was assessed by a percentage metric and quadratic weighted Cohen's kappa. Ranking accuracies were compared using repeated measurements analysis of variance. Reconstruction models trained with IQ‐Net score, MSE and SSIM were compared by paired t test. P < 0.05 was considered significant.Results: Compared to direct Likert scoring, ranking produced a higher level of agreement between radiologists (70.4% vs. 25%). Image ranking was subjective with a high level of intraobserver agreement () and lower interobserver agreement (). IQ‐Net and EfficientNet accurately predicted rankings with a reference image ( and ). However, EfficientNet resulted in images with artifacts and high MSE when used in denoising tasks while IQ‐Net optimized networks performed well for both denoising and reconstruction tasks.Data Conclusion: Image quality networks can be trained from image ranking and used to optimize DL tasks.Level of Evidence: 3Technical Efficacy: Stage 1
- Open Access
- 30 August 2024
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 21 (1) , 1-11
CSF dynamics throughout the ventricular system using 4D flow MRI: associations to arterial pulsatility, ventricular volumes, and age
Cerebrospinal fluid (CSF) dynamics are increasingly studied in aging and neurological disorders. Models of CSF-mediated waste clearance suggest that altered CSF dynamics could play a role in the accumulation of toxic waste in the CNS, with implications for Alzheimer’s disease and other proteinopathies. Therefore, approaches that enable quantitative and volumetric assessment of CSF flow velocities could be of value. In this study we demonstrate the feasibility of 4D flow MRI for simultaneous assessment of CSF dynamics throughout the ventricular system, and evaluate associations to arterial pulsatility, ventricular volumes, and age. In a cognitively unimpaired cohort (N = 43; age 41–83 years), cardiac-resolved 4D flow MRI CSF velocities were obtained in the lateral ventricles (LV), foramens of Monro, third and fourth ventricles (V3 and V4), the cerebral aqueduct (CA) and the spinal canal (SC), using a velocity encoding (venc) of 5 cm/s. Cerebral blood flow pulsatility was also assessed with 4D flow (venc = 80 cm/s), and CSF volumes were obtained from T1- and T2-weighted MRI. Multiple linear regression was used to assess effects of age, ventricular volumes, and arterial pulsatility on CSF velocities. Cardiac-driven CSF dynamics were observed in all CSF spaces, with region-averaged velocity range and root-mean-square (RMS) velocity encompassing from very low in the LVs (RMS 0.25 ± 0.08; range 0.85 ± 0.28 mm/s) to relatively high in the CA (RMS 6.29 ± 2.87; range 18.6 ± 15.2 mm/s). In the regression models, CSF velocity was significantly related to age in 5/6 regions, to CSF space volume in 2/3 regions, and to arterial pulsatility in 3/6 regions. Group-averaged waveforms indicated distinct CSF flow propagation delays throughout CSF spaces, particularly between the SC and LVs. Our findings show that 4D flow MRI enables assessment of CSF dynamics throughout the ventricular system, and captures independent effects of age, CSF space morphology, and arterial pulsatility on CSF motion.
- 30 August 2024
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 21 (1) , 1-11
Open AccessCSF dynamics throughout the ventricular system using 4D flow MRI: associations to arterial pulsatility, ventricular volumes, and age
Cerebrospinal fluid (CSF) dynamics are increasingly studied in aging and neurological disorders. Models of CSF-mediated waste clearance suggest that altered CSF dynamics could play a role in the accumulation of toxic waste in the CNS, with implications for Alzheimer’s disease and other proteinopathies. Therefore, approaches that enable quantitative and volumetric assessment of CSF flow velocities could be of value. In this study we demonstrate the feasibility of 4D flow MRI for simultaneous assessment of CSF dynamics throughout the ventricular system, and evaluate associations to arterial pulsatility, ventricular volumes, and age. In a cognitively unimpaired cohort (N = 43; age 41–83 years), cardiac-resolved 4D flow MRI CSF velocities were obtained in the lateral ventricles (LV), foramens of Monro, third and fourth ventricles (V3 and V4), the cerebral aqueduct (CA) and the spinal canal (SC), using a velocity encoding (venc) of 5 cm/s. Cerebral blood flow pulsatility was also assessed with 4D flow (venc = 80 cm/s), and CSF volumes were obtained from T1- and T2-weighted MRI. Multiple linear regression was used to assess effects of age, ventricular volumes, and arterial pulsatility on CSF velocities. Cardiac-driven CSF dynamics were observed in all CSF spaces, with region-averaged velocity range and root-mean-square (RMS) velocity encompassing from very low in the LVs (RMS 0.25 ± 0.08; range 0.85 ± 0.28 mm/s) to relatively high in the CA (RMS 6.29 ± 2.87; range 18.6 ± 15.2 mm/s). In the regression models, CSF velocity was significantly related to age in 5/6 regions, to CSF space volume in 2/3 regions, and to arterial pulsatility in 3/6 regions. Group-averaged waveforms indicated distinct CSF flow propagation delays throughout CSF spaces, particularly between the SC and LVs. Our findings show that 4D flow MRI enables assessment of CSF dynamics throughout the ventricular system, and captures independent effects of age, CSF space morphology, and arterial pulsatility on CSF motion.
- Open Access
- 14 August 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (5) , fcae276
Alzheimer’s disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults
Reduced brain volumes and more prominent white matter hyperintensities on MRI scans are commonly observed among older adults without cognitive impairment. However, it remains unclear whether rates of change in these measures among cognitively normal adults differ as a function of genetic risk for late-onset Alzheimer’s disease, including APOE-ɛ4, APOE-ɛ2 and Alzheimer’s disease polygenic risk scores (AD-PRS), and whether these relationships are influenced by other variables. This longitudinal study examined the trajectories of regional brain volumes and white matter hyperintensities in relationship to APOE genotypes (N = 1541) and AD-PRS (N = 1093) in a harmonized dataset of middle-aged and older individuals with normal cognition at baseline (mean baseline age = 66 years, SD = 9.6) and an average of 5.3 years of MRI follow-up (max = 24 years). Atrophy on volumetric MRI scans was quantified in three ways: (i) a composite score of regions vulnerable to Alzheimer’s disease (SPARE-AD); (ii) hippocampal volume; and (iii) a composite score of regions indexing advanced non-Alzheimer’s disease-related brain aging (SPARE-BA). Global white matter hyperintensity volumes were derived from fluid attenuated inversion recovery (FLAIR) MRI. Using linear mixed effects models, there was an APOE-ɛ4 gene-dose effect on atrophy in the SPARE-AD composite and hippocampus, with greatest atrophy among ɛ4/ɛ4 carriers, followed by ɛ4 heterozygouts, and lowest among ɛ3 homozygouts and ɛ2/ɛ2 and ɛ2/ɛ3 carriers, who did not differ from one another. The negative associations of APOE-ɛ4 with atrophy were reduced among those with higher education (P < 0.04) and younger baseline ages (P < 0.03). Higher AD-PRS were also associated with greater atrophy in SPARE-AD (P = 0.035) and the hippocampus (P = 0.014), independent of APOE-ɛ4 status. APOE-ɛ2 status (ɛ2/ɛ2 and ɛ2/ɛ3 combined) was not related to baseline levels or atrophy in SPARE-AD, SPARE-BA or the hippocampus, but was related to greater increases in white matter hyperintensities (P = 0.014). Additionally, there was an APOE-ɛ4 × AD-PRS interaction in relation to white matter hyperintensities (P = 0.038), with greater increases in white matter hyperintensities among APOE-ɛ4 carriers with higher AD-PRS. APOE and AD-PRS associations with MRI measures did not differ by sex. These results suggest that APOE-ɛ4 and AD-PRS independently and additively influence longitudinal declines in brain volumes sensitive to Alzheimer’s disease and synergistically increase white matter hyperintensity accumulation among cognitively normal individuals. Conversely, APOE-ɛ2 primarily influences white matter hyperintensity accumulation, not brain atrophy. Results are consistent with the view that genetic factors for Alzheimer’s disease influence atrophy in a regionally specific manner, likely reflecting preclinical neurodegeneration, and that Alzheimer’s disease risk genes contribute to white matter hyperintensity formation.
- 14 August 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (5) , fcae276
Open AccessAlzheimer’s disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults
Reduced brain volumes and more prominent white matter hyperintensities on MRI scans are commonly observed among older adults without cognitive impairment. However, it remains unclear whether rates of change in these measures among cognitively normal adults differ as a function of genetic risk for late-onset Alzheimer’s disease, including APOE-ɛ4, APOE-ɛ2 and Alzheimer’s disease polygenic risk scores (AD-PRS), and whether these relationships are influenced by other variables. This longitudinal study examined the trajectories of regional brain volumes and white matter hyperintensities in relationship to APOE genotypes (N = 1541) and AD-PRS (N = 1093) in a harmonized dataset of middle-aged and older individuals with normal cognition at baseline (mean baseline age = 66 years, SD = 9.6) and an average of 5.3 years of MRI follow-up (max = 24 years). Atrophy on volumetric MRI scans was quantified in three ways: (i) a composite score of regions vulnerable to Alzheimer’s disease (SPARE-AD); (ii) hippocampal volume; and (iii) a composite score of regions indexing advanced non-Alzheimer’s disease-related brain aging (SPARE-BA). Global white matter hyperintensity volumes were derived from fluid attenuated inversion recovery (FLAIR) MRI. Using linear mixed effects models, there was an APOE-ɛ4 gene-dose effect on atrophy in the SPARE-AD composite and hippocampus, with greatest atrophy among ɛ4/ɛ4 carriers, followed by ɛ4 heterozygouts, and lowest among ɛ3 homozygouts and ɛ2/ɛ2 and ɛ2/ɛ3 carriers, who did not differ from one another. The negative associations of APOE-ɛ4 with atrophy were reduced among those with higher education (P < 0.04) and younger baseline ages (P < 0.03). Higher AD-PRS were also associated with greater atrophy in SPARE-AD (P = 0.035) and the hippocampus (P = 0.014), independent of APOE-ɛ4 status. APOE-ɛ2 status (ɛ2/ɛ2 and ɛ2/ɛ3 combined) was not related to baseline levels or atrophy in SPARE-AD, SPARE-BA or the hippocampus, but was related to greater increases in white matter hyperintensities (P = 0.014). Additionally, there was an APOE-ɛ4 × AD-PRS interaction in relation to white matter hyperintensities (P = 0.038), with greater increases in white matter hyperintensities among APOE-ɛ4 carriers with higher AD-PRS. APOE and AD-PRS associations with MRI measures did not differ by sex. These results suggest that APOE-ɛ4 and AD-PRS independently and additively influence longitudinal declines in brain volumes sensitive to Alzheimer’s disease and synergistically increase white matter hyperintensity accumulation among cognitively normal individuals. Conversely, APOE-ɛ2 primarily influences white matter hyperintensity accumulation, not brain atrophy. Results are consistent with the view that genetic factors for Alzheimer’s disease influence atrophy in a regionally specific manner, likely reflecting preclinical neurodegeneration, and that Alzheimer’s disease risk genes contribute to white matter hyperintensity formation.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Examining Complex Relationships among Cerebrovascular, β‐Amyloid, Tau and Cognitive Measures in a Cognitively Unimpaired Late‐Middle Aged Sample
Background: Recent research linking vascular risk with promotion of tau pathology in the inferior temporal cortex (ITC) suggests a potential mechanism connecting cerebrovascular risk to AD pathology and cognitive decline among cognitively unimpaired (CU) individuals (Yau et al, 2022).We used MRI White Matter Hyperintensity (WMH), a neuroimaging marker of chronic cerebral small‐vessel disease/cerebrovascular disease, to further elucidate longitudinal relationships between cerebrovascular risk, PET AD pathological burden, and cognition.Method: We examined baseline CU late middle‐aged adults from the University of Wisconsin’s Alzheimer’s disease research cohorts. β‐Amyloid burden was measured with 11C‐Pittsburgh compound B (“PiB”; DVR derived from a 0‐70 min dynamic PET scan; PET A+ threshold∼1.16 DVR/∼CL 17). Cerebrovascular risk was quantified using WMH volumes (T2‐FLAIR images; SPM Lesion Segmentation Tool). Tau burden was measured with florquinitau PET (MK6240 SUVR from 70‐90 min post‐injection). Tau outcomes included bilateral volume‐weighted averages for ITC, Medial temporal lobe (MTL) and Meta‐temporal (MTC) composites. Biomarker values were z‐transformed relative to CU/PET A‐ values. Random intercept models examined interactive effects of baseline WMH and Aβ levels on longitudinal tau (covarying baseline tau age, sex, APOE ε4 count). We modeled time two ways: years since baseline PiB (TimePiB1; replicating Yau, et al models); and, in parallel models, amyloid duration (years) at tau scans was substituted for years since PiB1 in the A+ subset (TimePiB1/PiB+). We also used LME to examine Aβ, WMH, and time interactions in longitudinal cognition (PACC3 and Digit Symbol Substitution).Result: The mean(SD) tau baseline age was 67.9(6.8) years (sample details in Table1). The most parsimonious models using TimePiB1 included WMH*Aβ*Time for ITC and MTC and WMH*Aβ for MTL. Patterns showed a synergistic effect of WMH and Aβ on tau accumulation that was attenuated using TimePiB1/PiB+ where the most parsimonious models included Aβ_status*TimePiB1/PiB+ (ITC, MTC) or WMH*Aβ_status*TimePiB1/PiB+ (MTL; Figure1). AICc model fits were substantially better using TimePiB1/PiB+. Both Aβ and WMH contributed to cognitive trajectories (Figure2).Conclusion: Although cerebrovascular risk’s apparent contribution to tau accumulation varied depending on how time was modeled, results suggest that cerebrovascular risk may complement imaging biomarkers in assessing risk of tau accumulation and cognitive decline in preclinical Alzheimer disease.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessExamining Complex Relationships among Cerebrovascular, β‐Amyloid, Tau and Cognitive Measures in a Cognitively Unimpaired Late‐Middle Aged Sample
Background: Recent research linking vascular risk with promotion of tau pathology in the inferior temporal cortex (ITC) suggests a potential mechanism connecting cerebrovascular risk to AD pathology and cognitive decline among cognitively unimpaired (CU) individuals (Yau et al, 2022).We used MRI White Matter Hyperintensity (WMH), a neuroimaging marker of chronic cerebral small‐vessel disease/cerebrovascular disease, to further elucidate longitudinal relationships between cerebrovascular risk, PET AD pathological burden, and cognition.Method: We examined baseline CU late middle‐aged adults from the University of Wisconsin’s Alzheimer’s disease research cohorts. β‐Amyloid burden was measured with 11C‐Pittsburgh compound B (“PiB”; DVR derived from a 0‐70 min dynamic PET scan; PET A+ threshold∼1.16 DVR/∼CL 17). Cerebrovascular risk was quantified using WMH volumes (T2‐FLAIR images; SPM Lesion Segmentation Tool). Tau burden was measured with florquinitau PET (MK6240 SUVR from 70‐90 min post‐injection). Tau outcomes included bilateral volume‐weighted averages for ITC, Medial temporal lobe (MTL) and Meta‐temporal (MTC) composites. Biomarker values were z‐transformed relative to CU/PET A‐ values. Random intercept models examined interactive effects of baseline WMH and Aβ levels on longitudinal tau (covarying baseline tau age, sex, APOE ε4 count). We modeled time two ways: years since baseline PiB (TimePiB1; replicating Yau, et al models); and, in parallel models, amyloid duration (years) at tau scans was substituted for years since PiB1 in the A+ subset (TimePiB1/PiB+). We also used LME to examine Aβ, WMH, and time interactions in longitudinal cognition (PACC3 and Digit Symbol Substitution).Result: The mean(SD) tau baseline age was 67.9(6.8) years (sample details in Table1). The most parsimonious models using TimePiB1 included WMH*Aβ*Time for ITC and MTC and WMH*Aβ for MTL. Patterns showed a synergistic effect of WMH and Aβ on tau accumulation that was attenuated using TimePiB1/PiB+ where the most parsimonious models included Aβ_status*TimePiB1/PiB+ (ITC, MTC) or WMH*Aβ_status*TimePiB1/PiB+ (MTL; Figure1). AICc model fits were substantially better using TimePiB1/PiB+. Both Aβ and WMH contributed to cognitive trajectories (Figure2).Conclusion: Although cerebrovascular risk’s apparent contribution to tau accumulation varied depending on how time was modeled, results suggest that cerebrovascular risk may complement imaging biomarkers in assessing risk of tau accumulation and cognitive decline in preclinical Alzheimer disease.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Longitudinal changes in blood flow, vessel pulsatility, and trans‐capillary pulse wave delay in small vessel disease and amyloid biomarker positive
Background: This work characterized longitudinal changes in cerebrovascular health in humans with and without presence of small vessel disease (SVD) and amyloid‐β using different neuroimaging techniques.Method: Participants (n = 41) were biomarker characterized into three groups: amyloid and SVD negative (A‐V‐; “control”), SVD positive (A‐V+), and amyloid positive (A+V‐). All were cognitively unimpaired except two participants clinically diagnosed with MCI (A‐V+) and dementia (A+V‐) (Table 1). MRI: Vascular imaging: Whole‐brain 4D‐Flow data were acquired to characterize cerebrovascular health. Two MRI time‐points were used to establish 4D‐Flow‐based longitudinal changes. Measurements were extracted from intracranial arteries and veins and included blood flow, vessel pulsatility index, and trans‐capillary pulse wave delay (TPWD). TPWD was defined as the time shift between arterial and venous cardiac waveforms. Structural imaging: TIV‐normalized WMH volumes were segmented from T2‐FLAIR images and used as surrogate for SVD. V+/‐ thresholds were determined from Gaussian Mixture Model on 930 participants. PET: Amyloid‐β burden was assessed using 11C‐PiB PET imaging. Amyloid positivity was established as mean cortical PiB DVR >1.16. Vascular changes were assessed using Kruskal‐Wallis followed by multiple comparisons (P<0.05 significance).Result: After ∼4.5 years, middle cerebral arteries (MCAs) blood flow decreased significantly more in amyloid than SVD groups, while vessel pulsatility increased significantly more in amyloid compared to SVD (Fig.1). TPWD shortened significantly in SVD compared to amyloid and control groups. All groups showed a decreased in blood flow, increased in vessel pulsatility and shortening of TPWD with time. At the time of the last MRI visit, MCAs blood flow was somewhat higher in SVD compared to amyloid and control groups, but not significantly (Fig.2). Vessel pulsatility was similar between groups, yet slightly higher in SVD and amyloid groups. TPWD was significantly shorter in SVD compared to the amyloid group.Conclusion: This work demonstrates the feasibility to measure longitudinal cerebrovascular changes using 4D‐Flow MRI in the context of SVD and AD biomarker positive groups. Preliminary results indicate 4D‐Flow‐based vascular markers can detect differences between SVD and amyloid groups both longitudinally and cross‐sectionally. Cerebrovascular changes in A+ suggest decreased metabolism and increased macro‐vessel stiffness, while findings in SVD positive supports stiffness of the micro‐circulation and capillaries.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Open AccessLongitudinal changes in blood flow, vessel pulsatility, and trans‐capillary pulse wave delay in small vessel disease and amyloid biomarker positive
Background: This work characterized longitudinal changes in cerebrovascular health in humans with and without presence of small vessel disease (SVD) and amyloid‐β using different neuroimaging techniques.Method: Participants (n = 41) were biomarker characterized into three groups: amyloid and SVD negative (A‐V‐; “control”), SVD positive (A‐V+), and amyloid positive (A+V‐). All were cognitively unimpaired except two participants clinically diagnosed with MCI (A‐V+) and dementia (A+V‐) (Table 1). MRI: Vascular imaging: Whole‐brain 4D‐Flow data were acquired to characterize cerebrovascular health. Two MRI time‐points were used to establish 4D‐Flow‐based longitudinal changes. Measurements were extracted from intracranial arteries and veins and included blood flow, vessel pulsatility index, and trans‐capillary pulse wave delay (TPWD). TPWD was defined as the time shift between arterial and venous cardiac waveforms. Structural imaging: TIV‐normalized WMH volumes were segmented from T2‐FLAIR images and used as surrogate for SVD. V+/‐ thresholds were determined from Gaussian Mixture Model on 930 participants. PET: Amyloid‐β burden was assessed using 11C‐PiB PET imaging. Amyloid positivity was established as mean cortical PiB DVR >1.16. Vascular changes were assessed using Kruskal‐Wallis followed by multiple comparisons (P<0.05 significance).Result: After ∼4.5 years, middle cerebral arteries (MCAs) blood flow decreased significantly more in amyloid than SVD groups, while vessel pulsatility increased significantly more in amyloid compared to SVD (Fig.1). TPWD shortened significantly in SVD compared to amyloid and control groups. All groups showed a decreased in blood flow, increased in vessel pulsatility and shortening of TPWD with time. At the time of the last MRI visit, MCAs blood flow was somewhat higher in SVD compared to amyloid and control groups, but not significantly (Fig.2). Vessel pulsatility was similar between groups, yet slightly higher in SVD and amyloid groups. TPWD was significantly shorter in SVD compared to the amyloid group.Conclusion: This work demonstrates the feasibility to measure longitudinal cerebrovascular changes using 4D‐Flow MRI in the context of SVD and AD biomarker positive groups. Preliminary results indicate 4D‐Flow‐based vascular markers can detect differences between SVD and amyloid groups both longitudinally and cross‐sectionally. Cerebrovascular changes in A+ suggest decreased metabolism and increased macro‐vessel stiffness, while findings in SVD positive supports stiffness of the micro‐circulation and capillaries.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S24)
Using Different Time Operationalizations To Investigate Relationships Among Amyloid PET, White Matter Hyperintensities, And Cognition In A Cognitively Unimpaired Sample
Background: Amyloid‐PET and white matter hyperintensities (WMH) associations in older adults have variously been interpreted as separate or dependent processes. In this study, we examine evidence for a temporal relationship between amyloid‐PET and WMH and investigate how both contribute to cognitive decline in a baseline cognitively unimpaired (CU) sample.Method: We analyzed longitudinal WMH and PACC3 cognition in n = 240 Wisconsin Registry for Alzheimer’s Prevention participants who were CU at cognitive baseline with ≥1 amyloid‐PET and T2‐FLAIR scan. Amyloid burden was assessed using [C‐11]Pittsburgh Compound B (PiB) PET and a multi‐ROI DVR value; DVR>1.19 = PiB+. WMH lesion volume was segmented and summed by the Lesion Segmentation Tool (LST) version 1.2.3 in SPM12 from T1‐weighted and T2‐weighted FLAIR scans; TIV‐adjusted WMH >2.06 = WMH+. Sampled iterative local approximation (SILA) modeling aligned biomarker levels to positivity duration scale (years = 0 at biomarker+ threshold). To investigate how amyloid burden relates to WMH trajectories, time at each WMH scan was operationalized four ways: age, ∼WMH+ duration, years_since_baseline_scan, and ∼PiB+ duration. We compared model fits and interaction effects for the various PiB status*time interactions (mixed effects models; retaining significant quadratic time terms; random slopes and intercepts). We also examined whether PACC3 age‐related trajectories differed by PiB/WMH +/‐ groups (at last scan).Result: More women were WMH+ and APOE4 was more common among PiB+ (see also Table1). Significant interactions using age or years_since_baseline_scan suggested slightly faster WMH accumulation in PiB+ vs PiB‐ at older ages. In parallel models, WMH+ duration*PiB status and PiB+ duration*PiB status did not show differences between PiB+ and PiB‐ WMH trajectories. Time operationalized as WMH+ duration yielded the best fitting model (see Table2 and Fig1A‐D). PACC3 decline was fastest in the PiB+/WMH+ group, followed by PiB+/WMH‐ (Fig1E). PiB+ was more common than WMH+ and tended to precede it when both were present (Table1; Fig1F).Conclusion: In this baseline CU sample, WMH+ was less common and occurred later in life, on average, than PiB+. Associations between amyloid burden and WMH trajectories were driven by older ages, suggesting potential unidentified age‐related mediators in this relationship. Presence of both amyloid and WMH was associated with fastest preclinical cognitive decline.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S24)
Open AccessUsing Different Time Operationalizations To Investigate Relationships Among Amyloid PET, White Matter Hyperintensities, And Cognition In A Cognitively Unimpaired Sample
Background: Amyloid‐PET and white matter hyperintensities (WMH) associations in older adults have variously been interpreted as separate or dependent processes. In this study, we examine evidence for a temporal relationship between amyloid‐PET and WMH and investigate how both contribute to cognitive decline in a baseline cognitively unimpaired (CU) sample.Method: We analyzed longitudinal WMH and PACC3 cognition in n = 240 Wisconsin Registry for Alzheimer’s Prevention participants who were CU at cognitive baseline with ≥1 amyloid‐PET and T2‐FLAIR scan. Amyloid burden was assessed using [C‐11]Pittsburgh Compound B (PiB) PET and a multi‐ROI DVR value; DVR>1.19 = PiB+. WMH lesion volume was segmented and summed by the Lesion Segmentation Tool (LST) version 1.2.3 in SPM12 from T1‐weighted and T2‐weighted FLAIR scans; TIV‐adjusted WMH >2.06 = WMH+. Sampled iterative local approximation (SILA) modeling aligned biomarker levels to positivity duration scale (years = 0 at biomarker+ threshold). To investigate how amyloid burden relates to WMH trajectories, time at each WMH scan was operationalized four ways: age, ∼WMH+ duration, years_since_baseline_scan, and ∼PiB+ duration. We compared model fits and interaction effects for the various PiB status*time interactions (mixed effects models; retaining significant quadratic time terms; random slopes and intercepts). We also examined whether PACC3 age‐related trajectories differed by PiB/WMH +/‐ groups (at last scan).Result: More women were WMH+ and APOE4 was more common among PiB+ (see also Table1). Significant interactions using age or years_since_baseline_scan suggested slightly faster WMH accumulation in PiB+ vs PiB‐ at older ages. In parallel models, WMH+ duration*PiB status and PiB+ duration*PiB status did not show differences between PiB+ and PiB‐ WMH trajectories. Time operationalized as WMH+ duration yielded the best fitting model (see Table2 and Fig1A‐D). PACC3 decline was fastest in the PiB+/WMH+ group, followed by PiB+/WMH‐ (Fig1E). PiB+ was more common than WMH+ and tended to precede it when both were present (Table1; Fig1F).Conclusion: In this baseline CU sample, WMH+ was less common and occurred later in life, on average, than PiB+. Associations between amyloid burden and WMH trajectories were driven by older ages, suggesting potential unidentified age‐related mediators in this relationship. Presence of both amyloid and WMH was associated with fastest preclinical cognitive decline.